Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Mechanisms of Fibroblast Growth Factor 2 Intracellular Processing:  A Kinetic Analysis of the Role of Heparan Sulfate Proteoglycans†

Identifieur interne : 002455 ( Main/Exploration ); précédent : 002454; suivant : 002456

Mechanisms of Fibroblast Growth Factor 2 Intracellular Processing:  A Kinetic Analysis of the Role of Heparan Sulfate Proteoglycans†

Auteurs : Gizette V. Sperinde [États-Unis] ; Matthew A. Nugent [États-Unis]

Source :

RBID : ISTEX:CF0F213D60C325EE792FA567983A500DA0EECBC5

Abstract

The interaction of fibroblast growth factor 2 (FGF-2) with heparan sulfate proteoglycans (HSPG) has been demonstrated to enhance receptor binding and alter the intracellular distribution of internalized FGF-2. In the present study, the intracellular fate of FGF-2 was analyzed in vascular smooth muscle cells (VSMC) under native and HSPG-deficient conditions. HSPG-deficient cells were generated by treatment with sodium chlorate. Cells were incubated with FGF-2 at 37 °C for prolonged periods (0−48 h) to allow for FGF-2 uptake and processing. Processing of FGF-2 occurred in stages. Initially a family of low molecular weight (LMW) fragments (4−10 kDa) were detected that accumulated to much higher (∼10-fold) levels in native compared to heparan sulfate-deficient cells. Pulse−chase experiments revealed that the half-life of these LMW intermediates was significantly greater in native (∼18 h) compared to HSPG-deficient cells (∼4 h). Rate constants for FGF-2 processing were derived by modeling the uptake and processing of FGF-2 as a set of first-order differential equations. The kinetic analysis indicated that the greatest differences between native and HSPG-deficient VSMC was in the formation of LMW and further suggested that these FGF-2 products appear to represent a stable subpool of internal FGF-2 that is favored in cells that contain HSPG. Thus, HSPG might function as a cellular switch between immediate and prolonged signal activation by heparin-binding growth factors such as FGF-2. In the absence of HSPG, FGF-2 can interact with and activate its receptor, yet in the presence of HSPG, FGF-2 might be able to mediate prolonged or unique biological responses through intracellular processes.

Url:
DOI: 10.1021/bi992243d


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Mechanisms of Fibroblast Growth Factor 2 Intracellular Processing:  A Kinetic Analysis of the Role of Heparan Sulfate Proteoglycans†</title>
<author>
<name sortKey="Sperinde, Gizette V" sort="Sperinde, Gizette V" uniqKey="Sperinde G" first="Gizette V." last="Sperinde">Gizette V. Sperinde</name>
</author>
<author>
<name sortKey="Nugent, Matthew A" sort="Nugent, Matthew A" uniqKey="Nugent M" first="Matthew A." last="Nugent">Matthew A. Nugent</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:CF0F213D60C325EE792FA567983A500DA0EECBC5</idno>
<date when="2000" year="2000">2000</date>
<idno type="doi">10.1021/bi992243d</idno>
<idno type="url">https://api.istex.fr/ark:/67375/TPS-9DV1S2MW-W/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000828</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000828</idno>
<idno type="wicri:Area/Istex/Curation">000828</idno>
<idno type="wicri:Area/Istex/Checkpoint">001272</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001272</idno>
<idno type="wicri:doubleKey">0006-2960:2000:Sperinde G:mechanisms:of:fibroblast</idno>
<idno type="wicri:Area/Main/Merge">002483</idno>
<idno type="wicri:Area/Main/Curation">002455</idno>
<idno type="wicri:Area/Main/Exploration">002455</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Mechanisms of Fibroblast Growth Factor 2 Intracellular Processing:  A Kinetic Analysis of the Role of Heparan Sulfate Proteoglycans
<ref type="bib" target="#bi992243dAF2">
<hi rend="superscript"></hi>
</ref>
</title>
<author>
<name sortKey="Sperinde, Gizette V" sort="Sperinde, Gizette V" uniqKey="Sperinde G" first="Gizette V." last="Sperinde">Gizette V. Sperinde</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Departments of Biochemistry and Ophthalmology, Boston University School of Medicine, Boston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Nugent, Matthew A" sort="Nugent, Matthew A" uniqKey="Nugent M" first="Matthew A." last="Nugent">Matthew A. Nugent</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Departments of Biochemistry and Ophthalmology, Boston University School of Medicine, Boston</wicri:cityArea>
</affiliation>
<affiliation wicri:level="3">
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea> Correspondence should be addressed to this author at the Department of Biochemistry, Room K225, Boston University School ofMedicine, 716 Albany St., Boston</wicri:regionArea>
<placeName>
<settlement type="city">Boston</settlement>
<region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Biochemistry</title>
<title level="j" type="abbrev">Biochemistry</title>
<idno type="ISSN">0006-2960</idno>
<idno type="eISSN">1520-4995</idno>
<imprint>
<publisher>American Chemical Society</publisher>
<date type="e-published" when="2000-03-10">2000</date>
<date when="2000-04-04">2000</date>
<biblScope unit="vol">39</biblScope>
<biblScope unit="issue">13</biblScope>
<biblScope unit="page" from="3788">3788</biblScope>
<biblScope unit="page" to="3796">3796</biblScope>
</imprint>
<idno type="ISSN">0006-2960</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0006-2960</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">The interaction of fibroblast growth factor 2 (FGF-2) with heparan sulfate proteoglycans (HSPG) has been demonstrated to enhance receptor binding and alter the intracellular distribution of internalized FGF-2. In the present study, the intracellular fate of FGF-2 was analyzed in vascular smooth muscle cells (VSMC) under native and HSPG-deficient conditions. HSPG-deficient cells were generated by treatment with sodium chlorate. Cells were incubated with FGF-2 at 37 °C for prolonged periods (0−48 h) to allow for FGF-2 uptake and processing. Processing of FGF-2 occurred in stages. Initially a family of low molecular weight (LMW) fragments (4−10 kDa) were detected that accumulated to much higher (∼10-fold) levels in native compared to heparan sulfate-deficient cells. Pulse−chase experiments revealed that the half-life of these LMW intermediates was significantly greater in native (∼18 h) compared to HSPG-deficient cells (∼4 h). Rate constants for FGF-2 processing were derived by modeling the uptake and processing of FGF-2 as a set of first-order differential equations. The kinetic analysis indicated that the greatest differences between native and HSPG-deficient VSMC was in the formation of LMW and further suggested that these FGF-2 products appear to represent a stable subpool of internal FGF-2 that is favored in cells that contain HSPG. Thus, HSPG might function as a cellular switch between immediate and prolonged signal activation by heparin-binding growth factors such as FGF-2. In the absence of HSPG, FGF-2 can interact with and activate its receptor, yet in the presence of HSPG, FGF-2 might be able to mediate prolonged or unique biological responses through intracellular processes.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Massachusetts</li>
</region>
<settlement>
<li>Boston</li>
</settlement>
</list>
<tree>
<country name="États-Unis">
<region name="Massachusetts">
<name sortKey="Sperinde, Gizette V" sort="Sperinde, Gizette V" uniqKey="Sperinde G" first="Gizette V." last="Sperinde">Gizette V. Sperinde</name>
</region>
<name sortKey="Nugent, Matthew A" sort="Nugent, Matthew A" uniqKey="Nugent M" first="Matthew A." last="Nugent">Matthew A. Nugent</name>
<name sortKey="Nugent, Matthew A" sort="Nugent, Matthew A" uniqKey="Nugent M" first="Matthew A." last="Nugent">Matthew A. Nugent</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002455 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002455 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:CF0F213D60C325EE792FA567983A500DA0EECBC5
   |texte=   Mechanisms of Fibroblast Growth Factor 2 Intracellular Processing:  A Kinetic Analysis of the Role of Heparan Sulfate Proteoglycans†
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021